For more information or confidential assistance
Call 800-306-3180

Alexander Popovich

FDA Weighs in on Benicar Heart Risks

The popular blood pressure medication known as Benicar has been the subject of several FDA reviews and clinical studies, as scientists attempt to discern the drug’s inherent risks. Manufactured by Daiichi Sanyo, Benicar (olmesartan medoxomil) was FDA approved more than 12 years ago as one... Read More

New Research on Benicar GI Complications

New research presented before the Digestive Disease Week convention suggests that Benicar users are at an increased risk for serious gastrointestinal problems after two years exposure to the blood pressure drug. The recent study on Benicar side effects, which has yet to be published online,... Read More